Skip to main content
. 2014 Dec 15;20:2666–2676. doi: 10.12659/MSM.892476

Figure 3A–C.

Figure 3A–C

Meta-analysis of the effect of EGFR-TKIs on OS in first-line and second-line settings. Comparison of the effect on OS between EGFR-TKIs and chemotherapy in first-line setting (A) and in second-line setting (B); Comparison of the effect on OS in mut+ patients in first-line setting (C) and in second-line setting (D); Comparison of the effect on OS in mut− patients in first-line setting (E) and in second-line setting (F).